Eckert & Ziegler SE's latest marketcap:
As of 08/12/2025, Eckert & Ziegler SE's market capitalization has reached $4.22 B. According to our data, Eckert & Ziegler SE is the 3848th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | 4.22 B |
| Revenue (ttm) | 349.19 M |
| Net Income (ttm) | 42.75 M |
| Shares Out | 63.19 M |
| EPS (ttm) | 2.03 |
| Forward PE | 23.95 |
| Ex-Dividend Date | 06/19/2025 |
| Earnings Date | 08/08/2025 |
Eckert & Ziegler SE's yearly market capitalization.
| Date | Market Cap(€) | Market Cap(USD) | Change (%) | Global Rank |
|---|---|---|---|---|
| 08/12/2025 | €3.62 B | $4.22 B | 300.57% | 3848 |
| 12/30/2024 | €927.62 M | $960.29 M | 7.92% | 9027 |
| 12/29/2023 | €859.55 M | $948.72 M | -10.79% | 8967 |
| 12/30/2022 | €963.52 M | $1.03 B | -50.67% | 8095 |
| 12/30/2021 | €1.95 B | $2.22 B | 111.55% | 5738 |
| 12/30/2020 | €923.25 M | $1.13 B | -5.9% | 7441 |
| 12/30/2019 | €981.12 M | $1.1 B | 214.06% | 6477 |
| 12/28/2018 | €312.4 M | $358.19 M | 63.62% | 10813 |
| 12/29/2017 | €190.93 M | $229 M | 34.97% | 14007 |
| 12/30/2016 | €141.46 M | $148.76 M | 38.14% | 14103 |
Company Profile
About Eckert & Ziegler SE
Eckert & Ziegler SE is a global leader in the manufacturing and distribution of isotope technology components. Headquartered in Berlin, Germany, the company was founded in 1992 and rebranded from Eckert & Ziegler Strahlen- und Medizintechnik AG to Eckert & Ziegler SE in March 2024.
Business Segments
The company operates through two primary segments:
- Medical: Specializes in therapeutic and diagnostic solutions for healthcare.
- Isotope Products: Provides radiation sources and related services for industrial and scientific applications.
Key Products & Services
- Medical Solutions: Prostate cancer seeds, eye applicators (ruthenium-106 & iodine-125), brain seed implants, HDR brachytherapy, ophthalmological products, and radiopharmaceuticals.
- Therapeutic & Diagnostic Equipment: X-Ray therapy systems, GA-68 generators, radiosynthesis equipment, and quality-control tools.
- Industrial & Scientific Isotopes: Standard and high-activity radiation sources (CS-137, CO-60), oil well logging sources, blood irradiators, and bulk isotopes.
- Support Services: Environmental disposal, calibration sources, and plant engineering.
Applications & Markets
Eckert & Ziegler SE serves a diverse range of industries, including:
- Medical (oncology, ophthalmology, diagnostics)
- Scientific research
- Industrial analysis and instrumentation
Frequently Asked Questions
-
What is Eckert & Ziegler SE's (ETR-EUZ) current market cap?As of 08/12/2025, Eckert & Ziegler SE (including the parent company, if applicable) has an estimated market capitalization of $4.22 B USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
-
Where does Eckert & Ziegler SE (ETR-EUZ) rank globally by market cap?Eckert & Ziegler SE global market capitalization ranking is approximately 3848 as of 08/12/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.